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Abstract
Background: Manual acupuncture (MA) manipulations are one of the key factors influencing acupuncture effects
in traditional Chinese medicine theory. Different MA manipulations contain different stimulating parameters, thus
generating different acupuncture responses or effects. Evidence has demonstrated that acupuncture is effective for
functional dyspepsia (FD). However, the effects of different stimulating parameters of MA manipulations on FD
remain unclear.
Methods/design: This study is a randomized controlled trial with a four-arm, parallel-group structure. Patients with
FD with epigastric pain syndrome (EPS) will be included and randomly allocated into four groups: three MA
manipulation groups (separately treated with a frequency of 1 Hz, 2 Hz, or 3 Hz) and a control group. All groups
will receive omeprazole as a basic treatment and acupuncture: in the MA manipulation groups, the needles will be
manipulated manually with three different frequencies on the basis when de qi is reached, while in the control
group, the needles will be inserted without any manipulation. All patients will receive acupuncture treatment of
five consecutive sessions per week for 2 weeks and be followed up at 4, 8, and 12 weeks. The primary outcomes
of the study include patients’ response to the treatment. The secondary outcomes include dyspeptic symptoms,
quality of life, mental status, fasting serum gastrin, motilin, and ghrelin concentrations, and adverse events. The
protocol was approved by the Ethics committee of the First Affiliated Hospital of Zhejiang Chinese Medical
University (2016-K-057-01).
Discussion: The aim of this study is to evaluate the efficacy and safety of MA manipulations with different
stimulating parameters (different frequencies) on EPS in patients with FD.
Trial registration: Chinese Clinical Trial Registry, ChiCTR-IOR-16008189. Registered on 30 March 2016.
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Functional dyspepsia (FD) is a common disease causing
upper abdominal symptoms occurring in the absence of
organic disease that is likely to explain them. According to
the Rome III criteria, FD is divided into two subgroups:
epigastric pain syndrome (EPS) and postprandial distress
syndrome (PDS) [1]. FD has negative impacts on health
and also results in a high economic burden [2]. Standard
management of FD has not yet been established, and satis-
factory medications are also unavailable [3]. The manage-
ment of FD remains a major issue in health clinics.
In recent years, evidence-based medicine has demon-
strated that acupuncture is beneficial for relieving dyspep-
sia symptoms and associated negative emotions, thus
improving patient quality of life [4–6]. The acupoints and
acupuncture stimulus such as manual acupuncture (MA)
manipulations are the key elements inducing the effect.
Related research studies on treating FD with acupuncture
usually focus on the specificity or compatibility of acu-
points [6, 7]. However, the MA manipulations to treat FD
have not been fully investigated, causing difficulties in the
establishment and application of the best acupuncture
treatment for FD. Researchers had showed that different
MA manipulations contain different stimulating parame-
ters, thus generating different acupuncture responses or
effects [8–10]. Our previous study also demonstrated that
lifting-inserting MA manipulations with a frequency of 2
or 3 Hz could better inhibit acute visceral nociception in
rats with gastric distension than manipulations with a
frequency of 0.5 or 1 Hz [11]. Therefore, we assume that
the effects of MA manipulations with different stimulating
parameters on EPS in FD are different. The aim of this
study is to evaluate the different efficacies and safety of
lifting-inserting MA manipulations with different frequen-
cies on EPS in patients with FD.
Hypothesis
Based on our previous study, our hypothesis is that MA
manipulations with different frequencies have different
effects on dyspepsia symptoms and quality of life, and
that the high frequency will have a better effect than the
low frequency.
Objectives
The trial objectives are to clarify the different thera-
peutic effects and possible biological mechanisms of
lifting-inserting MA manipulations with different fre-
quencies on EPS in patients with FD.
Methods/design
Design
A four-armed parallel randomized controlled trial will
be conducted at the Department of Acupuncture and
Moxibustion, Zhejiang Provincial Hospital of TCM. The
flow diagram of the entire trial is shown in Fig. 1. The
Standard Protocol Items: Recommendations for Inter-
ventional Trials (SPIRIT) 2013 checklist is given in
Additional file 1.
Fig. 1 Flow diagram of the study
Hong et al. Trials  (2017) 18:102 Page 2 of 7
Participants
Inclusion criteria
Participants will be included if they: (1) meet the Rome
III FD criteria [1] (the new diagnostic standard for FD)
and have clinical symptoms of epigastric pain syndrome
(EPS); (2) are between the ages of 18 and 60 years; (3)
have received no other treatments related to the gastro-
intestinal system 1 week before enrollment and during
the study; (4) are willing to agree with the study protocol
and sign a written informed consent.
Exclusion criteria
Participants who present any of the following criteria will
be excluded: (1) serious structural disease (disease of heart,
lung, liver, kidney, digestive system, or hematopoietic
system) or mental illness; (2) other diseases that could
interfere with acupuncture treatment, e.g., clotting disor-
ders or leukopenia, active skin infection, pacemaker,
epilepsy, or anticoagulant therapy; (3) women who are
pregnant or breastfeeding; (4) difficulties in attending
the trial (e.g., paralysis, cancer, dementia, drug addic-
tion, time constraints, surgical operation); (5) diffi-
culty being followed up.
Recruitment, randomization, allocation concealment, and
blinding
The participants will be recruited through advertise-
ments in hospital websites and bulletin boards. The
participants who meet the inclusion criteria and have
signed written informed consents will be randomly
assigned to one of three MA manipulation groups
(groups A–C) or the control group in a 1:1:1:1 ratio by
central randomization performed by an independent
statistician from the Tigermed Pharmaceutical Science
and Technology Co., Ltd. Random numbers will be gen-
erated using the PROC PLAN of SAS 9.2 (SAS Institute
Inc., Cary, NC, USA). Opaque sealed envelopes will be
used to conceal the group to which participants have
been allocated. Investigators who have contact with the
participants should be unaware of the random alloca-
tion. To preserve masking, only the acupuncturists will
have access to the treatment allocation. The participants,
recruiters, and outcome assessors (the evaluator and the
statistician) will be unaware of the group assignments.
Intervention
Participants will be randomly allocated into one of four
groups: MA manipulation group A, B, C or the control
group. Everyone in each group will receive basic treat-
ment for FD (omeprazole, a classic acid suppressing
drug, is effective for the treatment of FD; 20 mg of
omeprazole 2 × daily, 30 min before meals) and acu-
puncture after randomization. The only difference in the
four groups is the acupuncture manipulation (e different
stimulating parameters of the MA manipulations).
Control group
The needles will be inserted into the same acupoints and
depth as for the MA manipulation groups but without
any manipulation. The treatment period or follow-up is
also the same as for the MA manipulation groups.
MA manipulation groups A, B, and C
The main acupoints ST36, PC6, and RN12 will be nee-
dled in each group. Additional acupoints will also be
used based on symptom differentiation. For stagnation
of liver qi, RN17 and LR13 (bilateral) are added; for
deficiency of spleen qi and stomach qi, one adds BL20
(bilateral) and BL21 (bilateral); for stomach disorder due
to liver qi, LR14 (bilateral) and LR3 (bilateral) are added;
for damp heat in middle Jiao, one adds SP9 (bilateral)
and ST44 (bilateral). Acupoints will be localized accord-
ing to the 2008 World Health Organization standards
[12]. Sterilized stainless steel needles (Φ0.25 mm × 25
mm or 0.25 mm × 40 mm, Tianjin Hua Hong Medical
Co., Ltd., Tianjin, China) will be used for all acupuncture
procedures. The length of the needle will be chosen
according to the acupoint.
After a de qi sensation is achieved, the needles in MA
manipulation groups A, B, and C will be respectively
manipulated manually with three different frequencies
(1, 2, or 3 Hz) of lifting-inserting MA manipulations (see
Table 1). The lifting-inserting MA manipulation proced-
ure is shown in Fig. 2. Briefly, after de qi, the lifting-
inserting MA manipulation will be performed for 1
minute, three times, separated by 10-minute intervals.
The entire procedure takes 33 minutes. The acupuncture
treatment consists of 10 sessions over a period of 2
weeks (one session per day, five continual sessions
per week, with a 2-day interval between the 2 weeks)
after randomization. All participants will be followed
up three times in 10 weeks after treatment (at 4, 8,
and 12 weeks).
All acupuncture procedures will be performed by the
same licensed acupuncturist who has more than 5 years
Table 1 Parameters of three different lifting-inserting MA






Operation of MA Depth
(mm)
Duration (s)






In neutral reinforcement and reduction, the needle is perpendicular to the
skin, and the force and amplitude of the lifting-inserting displacement is
uniform; the lifting-inserting distance is 2–3 mm
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of clinical experience. The acupuncturist will use a
metronome to maintain the rhythm. Before applying the
needling manipulations, the acupuncturist will repeat-
edly practice the manipulations on an ATP-II acupunc-
ture manipulation parameter tester (manufactured by
Shanghai University of Traditional Chinese Medicine,
Shang Xin Medical Technology Company). The ATP-II
device is used to measure various manual acupuncture
manipulation parameters through electrical resistance-
sensing technology. MA manipulation waveforms ap-
pear in real time on the computer screen. During the
practice phase, the acupuncturist regulates his manip-
ulations according to the waveforms shown on the
computer screen until the waveforms became repro-
ducible. This practice ensures that the angle, depth,
and frequency of lifting-inserting manipulation are
consistent and repeatable.
Outcomes
The primary outcomes of the study include patients’ re-
sponse to the treatment [13]. The secondary outcomes
include dyspeptic symptoms [14], quality of life [15],
mental status [16, 17], fasting serum gastrin, motilin,
and ghrelin concentrations, and adverse events. Each
outcome variable will be assessed before and after treat-
ment, and follow-up will be conducted at 4, 8, and 12
weeks in all groups (Fig. 3).
Primary outcomes
Patients’ response to the treatment will be measured by
an improved response rate (IRR) [13]: for EPS, the im-
provement of at least two scores and/or no occurrence
of epigastric pain and epigastric burning included in the
scale are regarded as positive responses. The Symptom
Index for EPS is a 4-indicator scale assessing two main
dyspepsia symptoms (epigastric pain and epigastric
burning) with a scale ranging from 0 to 3. A score of 0
indicates symptoms not present; 1 indicates occasional
and mild symptoms that do not interfere with social ac-
tivities; 2 indicates prolonged and obvious symptoms
interfering with work or rest; and 3 indicates severe
symptoms with an impact on work or rest. The IRR is
the percentage of patients who are symptom-free or
have shown improvement in at least two scores at the
end of the treatment and follow-up.
Secondary outcomes
Dyspeptic symptoms will be assessed by the Chinese
version of the Nepean Dyspepsia Index (NDI) [14], in-
cluding the intensity, frequency, and level of interference
of postprandial fullness, early satiety, epigastric pain, and
epigastric burning sensation. The intensity of each
symptom is graded and scored as follows: 0, absent; 1,
mild; 2, moderate; 3, severe; 4, critical. The frequency of
each symptom is also graded: 0, absent; 1, occasionally
(1–2 days/week); 2, sometimes (3–5 days/week); 3,
frequently (every day, but intermittent symptoms); 4,
continuous symptoms. The level of interference of each
symptom is scored and graded as follows: 0, none; 1,
mild interference; 2, moderate interference; 3, severe
interference; 4, critical interference. The number in front
of each grading indicates the score of the corresponding
symptom; the score for each symptom in the checklist of
cardinal dyspeptic symptoms is calculated by adding its
scores in the corresponding frequency, severity, and level
of discomfort. The dyspeptic symptom sum score (DSSS)
is the sum score of the four symptoms in the checklist.
The quality of life will be evaluated by the Short-Form
36 questionnaire (SF-36) [15]. Mental status will be mea-
sured by the Zung Self-Rating Depression Scale (SDS)
[16] and Self-Rating Anxiety Scale (SAS) [17]. The SF-36
measures quality of life (QoL) across eight domains; the
score of each domain = [(actual raw score − lowest pos-
sible raw score)/raw score range] × 100. For the SDS
score, the following equation is used: SDS Index = Raw
Score × 1.25. The grading of the SDS is as follows: SDS
Index less than 53 points is considered normal, 53–62 is
considered mild depression, 63–72 as moderate depres-
sion, and 73 and higher as severe depression. For SAS
grading, the following categories are used: normal range
(less than 50), mild anxiety (50 to 59), moderate anxiety
(60 to 69), and severe anxiety (70 and higher).
Fasting serum levels of gastrin, motilin, and ghrelin
will be measured by the enzyme-linked immunosorbent
assay. A fasting venous blood sample will be drawn from
the basilic vein prior to breakfast early in the morning
before and after treatment.
Fig. 2 The lifting-inserting MA manipulation procedure
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Any adverse reactions of patients will be recorded in
the case report form (CRF), including swelling, pain,
bruise at the sites of needle insertion, or discomfort, pal-
pitation, dizziness, etc., after acupuncture.
Sample size
The sample size calculation is based on the results of
trials by Li et al. [18] and Ji et al. [19] and the recom-
mendation of acupuncture specialists in China. The
mean value of the NDI score in the 2.5 Hz group is
82.28, the standard deviation is 6.97; the mean value of
the NDI score in the 2 Hz group is 86.73, the standard
deviation is 7.10; the mean value of the NDI score in the
1 Hz group is 76.50, the standard deviation is 8.06; the
mean value of the NDI score in the control group is
65.85, the standard deviation is 16.47. To detect a sig-
nificant difference between any two groups with a power
of 90% and a type I error of 5%, the calculated number
of patients is 17. Considering a 30% dropout rate, the
total sample size required is 88 patients.
Statistical analysis
The statistical analysis will be performed by two inde-
pendent statisticians. The statisticians are blinded to
treatments and study protocol. Statistical analysis will be
conducted on the basis of an intention-to-treat (ITT)
analysis. Missing values will be imputed by the last ob-
servation carried forward (LOCF) method. Categorical
data will be analyzed with the McNemar chi-square test.
Continuous data will be analyzed by analysis of variance
(ANOVA). If the data trend over time and over time by
treatment interactions, the repeated-measures ANOVA
will be used. A P value less than 0.05 is regarded as
statistically significant.
Quality control and dropout criteria
All researchers will be required to undergo special train-
ing, including trial design, patient inclusion and exclu-
sion criteria, and proper completion of the CRF. All
practitioners, who have majored in acupuncture and re-
ceived an acupuncture degree, are qualified doctors of
traditional Chinese medicine. Patients who want to stop
participating in this study, do not complete the treatment
over two visits, violate the study protocol, withdraw con-
sent for participation, or use prohibited treatments for FD
will be dropped from the study. The reasons for dropouts
and withdrawals from the study will be fully recorded.
Discussion
This is a protocol for a randomized, double-blind,
controlled trial on MA manipulations with different
stimulating parameters on EPS in patients with FD. Ac-
cording to the Rome III criteria, FD can be divided into
two subgroups: epigastric pain syndrome (EPS) and
postprandial distress syndrome (PDS) [1]. The differ-
ences in pathological mechanisms between EPS and PDS
have been discussed controversially in the past. However,
some new research studies have shown that these two
Fig. 3 Schedule of enrollment, interventions, and assessments
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subgroups differ in risk factors and pathophysiology, so
their pathological mechanisms are different [20, 21]. EPS
and PDS should be treated with different approaches
[22]. The diagnosis and treatment guidelines of dyspep-
sia in China also point out that clinical trials should
separately study EPS and PDS. At present, acupuncture
is widely used to treat disease pain, and acupuncture an-
algesia has gained worldwide acceptance. Therefore, we
have chosen FD patients with EPS for this research.
Creating proper control groups in acupuncture clinical
research is a conundrum. Rather than look for a better
placebo, we designed the trial so that all patients in each
group would receive acupuncture using the same nee-
dles, inserted to the same depth at the same acupoints.
What differed between the groups is the frequency to
which the needles are manipulated. In the control group,
the needles will be inserted without any manipulation.
The comparison is between four techniques. Because
each patient will receive some kind of acupuncture, it is
less likely that expectations will form a large part of the
therapeutic effect.
Acupuncture has been accepted to effectively treat dis-
eases by the insertion of needles into specific acupoints,
and the effect is manifested when the inserted needles are
manipulated by hand (manual acupuncture, MA) [23–25].
MA, consisting of needle manipulations by hand, such as
lifting, thrusting, twisting, twirling, or other complex com-
binations, is more traditional and widely used in practice.
Lifting-thrusting and twisting-twirling are the most basic
needle manipulations in MA. Researchers found that
different MA manipulations, containing different stimula-
tion parameters (including frequency, angle, and depth,
etc.) [8], could produce different physiological responses
[9, 10] and therapeutic effects [26, 27]. Lifting-thrusting
needle manipulation was more suitable for the treatment
of gastrointestinal movement disorders than twisting-
twirling manipulation [28, 29]. In our previous study, we
demonstrated that lifting-inserting needle manipulations
with a frequency of 2 or 3 Hz could better inhibit acute
visceral nociception in rats with gastric distension than
manipulations with a frequency of 0.5 or 1 Hz [11]. There-
fore, we assume that the effects of lifting-inserting manip-
ulations with different stimulation parameters (different
frequencies) on EPS in FD were distinct. In order to illu-
minate the rule and mechanism of lifting-inserting manip-
ulations with different frequencies treating FD with EPS,
we designed the randomized controlled double-blind trial
to reveal the difference in the effects of lifting-inserting
manipulations with different frequencies. At the same
time, we will observe some related hormone concentra-
tions and analyze the relations in effect, hormones, and
different manipulations. Thus, we can better optimize and
standardize the acupuncture protocols to guide the treat-
ment of FD with EPS.
Trial status
Participant recruitment is currently ongoing.
Additional file
Additional file 1: SPIRIT checklist. (DOCX 24 kb)
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